Noninvasive assessment of characteristics of novel anti-HER2

Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model

Full article: Development of High-Loading Trastuzumab PLGA Nanoparticles: A Powerful Tool Against HER2 Positive Breast Cancer Cells

Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition

Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET

Changes in ERa expression in response to HER2-directed therapy in the

Frontiers Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review

IJMS, Free Full-Text

Therapeutic strategy for anti-Her2 and Palbociclib resistant tumors

Anti-HER2 scFv expression, purification, and Western blot analysis. a

IJMS, Free Full-Text

Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model

Clinicopathological characteristics of the study population with